8,9-Dihydroxy-7,8,9-trimethyl-2a-oxy-2,3,4,4a,8,9,12,12b-octahydro-7H-5,11-dioxa-2a-aza-cycloundeca[cd]pentalene-6,10-dione

ID: ALA469442

Chembl Id: CHEMBL469442

Cas Number: 35337-98-5

PubChem CID: 21586627

Max Phase: Preclinical

Molecular Formula: C16H23NO7

Molecular Weight: 341.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Monocrotaline N-Oxide | Monocrotaline N-oxide|Monocrotaline oxide|2LCP0RBK6G|35337-98-5|Monocrotaline, N-oxide|(1R,4R,5R,6R,16R)-5,6-dihydroxy-4,5,6-trimethyl-13-oxido-2,8-dioxa-13-azoniatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione|UNII-2LCP0RBK6G|CHEMBL469442|14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione 4-oxide (13-alpha,14-alpha)-|20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, 4-oxide, (13-alpha,14-alpha)-|20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroShow More

Canonical SMILES:  C[C@H]1C(=O)O[C@@H]2CC[N+]3([O-])CC=C(COC(=O)[C@](C)(O)[C@]1(C)O)[C@H]23

Standard InChI:  InChI=1S/C16H23NO7/c1-9-13(18)24-11-5-7-17(22)6-4-10(12(11)17)8-23-14(19)16(3,21)15(9,2)20/h4,9,11-12,20-21H,5-8H2,1-3H3/t9-,11+,12+,15+,16-,17?/m0/s1

Standard InChI Key:  LHVAZUAALQTANZ-ANYXPJNNSA-N

Alternative Forms

  1. Parent:

Associated Targets(Human)

A204 (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Meloidogyne incognita (862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rhabditis sp. (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Phasmarhabditis hermaphrodita (5 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Heterodera schachtii (22 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pratylenchus penetrans (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 341.36Molecular Weight (Monoisotopic): 341.1475AlogP: -0.38#Rotatable Bonds: 0
Polar Surface Area: 116.12Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.49CX Basic pKa: 2.82CX LogP: -1.46CX LogD: -1.46
Aromatic Rings: 0Heavy Atoms: 24QED Weighted: 0.27Np Likeness Score: 3.09

References

1. Zalkow LH, Glinski JA, Gelbaum LT, Moore D, Melder D, Powis G..  (1988)  Semisynthetic pyrrolizidine alkaloid N-oxide antitumor agents. Esters of heliotridine.,  31  (8): [PMID:3397989] [10.1021/jm00403a008]
2. Zalkow LH, Asibal CF, Glinski JA, Bonetti SJ, Gelbaum LT, VanDerveer D, Powis G..  (1988)  Macrocyclic pyrrolizidine alkaloids from Senecio anonymus. Separation of a complex alkaloid extract using droplet counter-current chromatography.,  51  (4): [PMID:3210016] [10.1021/np50058a005]
3. Thoden TC, Boppré M, Hallmann J..  (2009)  Effects of pyrrolizidine alkaloids on the performance of plant-parasitic and free-living nematodes.,  65  (7): [PMID:19378265] [10.1002/ps.1764]

Source